Commercial Services Relating to Recombinant Antibody Discovery and Antigen Generation

Dstl has a requirement to access commercially available services related to antibody display library generation and antigen generation. The Authority (Dstl) operates a mature programme of hybridoma-based antibody discovery and characterisation and is rapidly maturing a recombinant antibody-based approach to replace or augment the current approach. There are a number of drivers in place that promote delivering many of the aspects of this programme within Industry whilst retaining safety and security limited steps, a...